Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA approves Lilly’s Onswik for type 2 diabetes in adults
The QWINT Phase III study enrolled more than 3,400 adults with type 2 diabetes across four registration studies. Credit: Andrzej Rostek/Shutterstock.com.
The QWINT Phase III study enrolled more than 3,400 adults with type 2 diabetes across four registration studies. Credit: Andrzej Rostek/Shutterstock.com.